VYOME HOLDINGS, INC. Deferred Income Tax Liabilities, Net
VYOME HOLDINGS, INC. (HIND) had Deferred Income Tax Liabilities, Net of $367.00 thousand as of 2022-06-30, per its 10-Q filed 2022-08-19.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2023-04-17
- 2022-06-30: Deferred Income Tax Liabilities, Net $367.00K.
- 2022-03-31: Deferred Income Tax Liabilities, Net $367.00K.
- 2021-12-31: Deferred Income Tax Liabilities, Net $367.00K; Deferred Income Tax Liabilities, Net as first filed $555.00K.
- 2021-09-30: Deferred Income Tax Liabilities, Net $615.00K.
| Period end | Deferred Income Tax Liabilities, Net | Deferred Income Tax Liabilities, Net as first filed |
|---|---|---|
| 2022-06-30 | $367.00K 10-Q · filed 2022-08-19 | |
| 2022-03-31 | $367.00K 10-Q · filed 2022-05-23 | |
| 2021-12-31 | $367.00K 10-K · filed 2023-04-17 | $555.00K 10-K · filed 2022-04-08 |
| 2021-09-30 | $615.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $615.00K 10-Q · filed 2021-08-16 | |
| 2020-12-31 | $615.00K 10-K · filed 2022-04-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |